- Home
- EVOK vs QNRX Comparison
EVOK vs QNRX Comparison
Compare EVOK & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- QNRX
- Stock Information
- Founded
- EVOK 2007
- QNRX 2018
- Country
- EVOK United States
- QNRX United States
- Employees
- EVOK N/A
- QNRX N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- QNRX Medical/Dental Instruments
- Sector
- EVOK Health Care
- QNRX Health Care
- Exchange
- EVOK Nasdaq
- QNRX Nasdaq
- Market Cap
- EVOK 5.4M
- QNRX 4.3M
- IPO Year
- EVOK 2013
- QNRX N/A
- Fundamental
- Price
- EVOK $5.21
- QNRX $7.78
- Analyst Decision
- EVOK
- QNRX
- Analyst Count
- EVOK 0
- QNRX 0
- Target Price
- EVOK N/A
- QNRX N/A
- AVG Volume (30 Days)
- EVOK 437.4K
- QNRX 2.6K
- Earning Date
- EVOK 11-06-2025
- QNRX 11-06-2025
- Dividend Yield
- EVOK N/A
- QNRX N/A
- EPS Growth
- EVOK N/A
- QNRX N/A
- EPS
- EVOK N/A
- QNRX N/A
- Revenue
- EVOK $12,794,859.00
- QNRX N/A
- Revenue This Year
- EVOK $57.38
- QNRX N/A
- Revenue Next Year
- EVOK $59.57
- QNRX N/A
- P/E Ratio
- EVOK N/A
- QNRX N/A
- Revenue Growth
- EVOK 70.02
- QNRX N/A
- 52 Week Low
- EVOK $1.94
- QNRX $5.01
- 52 Week High
- EVOK $12.32
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- EVOK 50.12
- QNRX 55.81
- Support Level
- EVOK $5.03
- QNRX $7.39
- Resistance Level
- EVOK $5.57
- QNRX $7.74
- Average True Range (ATR)
- EVOK 0.44
- QNRX 0.17
- MACD
- EVOK -0.09
- QNRX 0.10
- Stochastic Oscillator
- EVOK 11.17
- QNRX 100.00
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.